Drug insight: statins and gastrointestinal cancer.
Statins are popular lipid-lowering drugs that have had a great impact on the primary and secondary prevention of cardiovascular diseases. Basic and clinical research have also revealed that statins have biologic activities that go beyond lipid lowering, and suggest that they might have other therapeutic benefits. Perhaps the most exciting of these additional biologic effects is the finding that statins can exert an anticancer effect on cultured cancer cells, and in animal models. Clinical studies of statins for the treatment and prevention of cancer have, however, produced conflicting results. This review critically evaluates the current body of literature on the role of statins in the treatment and prevention of gastrointestinal cancers, with particular focus on clinical and observational studies.
Bhuket
Taft P
TP
University of Michigan, Ann Arbor, MI, USA.
Higgins
Peter D R
PD
D001661:Biliary Tract Neoplasms / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000517:prevention & control; D010190:Pancreatic Neoplasms / Q000517:prevention & control
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors